new_0222_0342|EWTX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0342|EWTX|Long Name|1|1|Edgewise Therapeutics Inc Total Current Assets (Quarterly) (USD)|Edgewise Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Edgewise Therapeutics Inc Inventories (Quarterly) (USD)|Edgewise Therapeutics Inc Net PP&E (Quarterly) (USD)|Edgewise Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Edgewise Therapeutics Inc Total Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Deposits (Quarterly) (USD)|Edgewise Therapeutics Inc Book Value (Quarterly) (USD)|Edgewise Therapeutics Inc Retained Earnings (Quarterly) (USD)|Edgewise Therapeutics Inc Treasury Stock (Quarterly) (USD)|Edgewise Therapeutics Inc EV to Revenues|Edgewise Therapeutics Inc EV to Earnings|Edgewise Therapeutics Inc EV to Free Cash Flow|Edgewise Therapeutics Inc EV to Assets (Quarterly)|Edgewise Therapeutics Inc PS Ratio|Edgewise Therapeutics Inc PE Ratio|Edgewise Therapeutics Inc Price to Book Value|Edgewise Therapeutics Inc PEG Ratio|Edgewise Therapeutics Inc Debt to Equity Ratio|Edgewise Therapeutics Inc Dividend Yield|Edgewise Therapeutics Inc Shareholder Yield (TTM)|Edgewise Therapeutics Inc Percent of Shares Outstanding Short|Edgewise Therapeutics Inc Total Receivables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Payables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Return on Invested Capital|Edgewise Therapeutics Inc Quality Ratio Score|Edgewise Therapeutics Inc Momentum Score|Edgewise Therapeutics Inc Beta (1Y)|Edgewise Therapeutics Inc Sustainable Growth Rate (TTM)|Edgewise Therapeutics Inc Institutional Investor Ownership Percentage|Edgewise Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Edgewise Therapeutics Inc Total Employees (Annual)|Edgewise Therapeutics Inc EPS Diluted (Quarterly) (USD)|Edgewise Therapeutics Inc Shares Outstanding|Edgewise Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Ordinary Shares Number (Quarterly)|Edgewise Therapeutics Inc Payout Ratio|Edgewise Therapeutics Inc Quick Ratio (Quarterly)|Edgewise Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Edgewise Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Edgewise Therapeutics Inc Effective Tax Rate (TTM)|Edgewise Therapeutics Inc Return on Equity|Edgewise Therapeutics Inc Net Income (TTM) (USD)|Edgewise Therapeutics Inc Revenue (TTM) (USD)|Edgewise Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Edgewise Therapeutics Inc Revenue (Quarterly) (USD)|Edgewise Therapeutics Inc Gross Profit (Quarterly) (USD)|Edgewise Therapeutics Inc SG&A Expense (Quarterly) (USD)|Edgewise Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Interest Income (Quarterly) (USD)|Edgewise Therapeutics Inc Price (USD)|Edgewise Therapeutics Inc Total Return Price (USD)|Edgewise Therapeutics Inc Enterprise Value (USD)|Edgewise Therapeutics Inc 30-Day Average Daily Volume|Edgewise Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0342|EWTX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0342|EWTX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0342|EWTX||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.4449339207|0|0|0|1.44|0|0|1.4449339207|0|15.3|0|91|91|0|0|0|0|0|0|91.3333333333|91|91.3333333333|27.875|0|91|0|0|91.3333333333|91.3333333333|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44298245614|1.44298245614|1.4449339207|1.44444444444|0
new_0222_0342|EWTX||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|227|0|0|0|225|0|0|227|0|20|0|3|3|0|0|0|0|0|0|6|3|6|8|0|3|0|0|6|6|0|0|3|0|0|0|0|6|6|6|6|228|228|227|198|0
new_0222_0342|EWTX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0342|EWTX|202003|202003|202003||||||||||||||||||||||||||||||||||20.3381||-0.1566||||||-0.1566|0||||||||0.281|-3.185|-3.185|0.063|||||
new_0222_0342|EWTX|202006|202006|202006||||||||||||||||||||||||||||||||||20.3381||-0.1944||||||-0.1944|0||||||||0.318|-3.954|-3.954|0.003|||||
new_0222_0342|EWTX|202009|202009|202009||||||||||||||||||||||||||||||||||20.3381||-0.1791||||||-0.1791|0||||||||0.405|-3.642|-3.642|0.001|||||
new_0222_0342|EWTX|202012|202012|202012|129.645|129.094||0.516||164.556|4.342|160.214||-33.42|-34.147|||||||||||||||1.58|0|||||||46.567|19|-0.1362|||49.262|||-0.1362||||-17.123|||||1.205|-6.342|-6.342|0.002|||||
new_0222_0342|EWTX|202103|202103|202103|310.545|309.871||0.499||4.851|4.851|0||306.394|-40.962||||-70.8971||||5.2245|||0||1.0864||1.621|0.005|||||||1.5599|22|-4.37|49.2543||49.2543|||-4.37|-187.051|||-20.753|||||1.497|-6.815|-6.815|0.042|32.5|32.5|1290.8938||
new_0222_0342|EWTX|202104|202103|202103|||||||||||||||-60.4554||||4.604|||0||2.0046|||||||||||||49.2543||||||||||||||||||28.64|28.64|1100.7722||
new_0222_0342|EWTX|202105|202103|202103|||||||||||||||-61.0776||||4.641|||0||2.1291|||||||||||||||||||||||||||||||28.87|28.87|1112.1006|134401.0333|
new_0222_0342|EWTX|202106|202106|202106|302.969|299.151||0.524||6.739|6.739|0||296.749|-51.315||||-31.4746||||3.5409|||0||3.9577||2.816|0.005|||||||49.2584|26|-0.21|49.262||49.262|||-0.21|0.903|||-27.152|||||2.599|-10.353|-10.353|0.107|21.33|21.33|751.6125|266735.0667|
new_0222_0342|EWTX|202107|202106|202106|||||||||||||||-23.5943||||2.9068|||0||4.181|||||||||||||49.262||||||||||||||||||17.51|17.51|563.4316|263603.5333|
new_0222_0342|EWTX|202108|202106|202106|||||||||||||||-20.1492||||2.6295|||0||4.2633|||||||||||||||||||||||||||||||15.84|15.84|481.1641|68447.5333|
new_0222_0342|EWTX|202109|202109|202109|293.242|290.484||0.911||9.049|8.754|0.295||285.399|-64.264||||-18.0053||||2.8672|||0||3.2113||2.292|0.005|||||||49.2649|30|-0.26|49.2958||49.2958|||-0.26|0|||-36.459|||||3.196|-12.949|-12.949|0.127|16.6|16.6|527.8263|64083.2333|
new_0222_0342|EWTX|202110|202109|202109|||||||||||||||-17.8372||||2.85|||0||2.8281|||||||||||||49.2958||||||||||||||||||16.5|16.5|522.8967|94430.2333|
new_0222_0342|EWTX|202111|202109|202109|||||||||||||||-19.3842||||3.0089|||0||4.388|||||||||||||||||||||||||||||||17.42|17.42|568.2488|146864.6667|
new_0222_0342|EWTX|202112|202112|202112|||||||||||||||-15.7856||||2.6393|||0||7.1118|||||||||||||||||||||||||||||||15.28|15.28|462.7558|378933.8333|
new_0222_0342|EWTX|202201|202112|202112|||||||||||||||-12.9606||||2.3491|||0||8.0904|||||||||||||||||||||||||||||||13.6|13.6|379.9389|679420.9667|
new_0222_0342|EWTX|202202|202112|202112|||||||||||||||-10.3709||||2.0157|||0|||||||||||||||||||||||||||||||||11.67|11.67|304.0233|364668.4|